Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Veliparib + Temozolomide in Metastatic Melanoma
NCT00804908Phase 2Completed
- Sponsor
- AbbVie Inc.
- Start
- Feb 2009
- Primary completion
- Jan 2016
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of veliparib in melanoma, sponsored by AbbVie Inc.. Started Feb 2009; status: completed.
02
Drugs
veliparib
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00804908.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00804908.